Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
AIDS (London, England)|September 9, 2004
High incidence of atypical mycobacteriosis in African HIV-infected adults with low CD4 cell counts: a 6-year cohort study in Côte d'IvoireDominique Bonard, Eugène Messou, Catherine Seyler, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 7, 2006
Incidence of neutropenia in HIV-infected African adults receiving co-trimoxazole prophylaxis: a 6-year cohort study in Abidjan, Côte d'IvoireSiaka Toure, Delphine Gabillard, André Inwoley, et al.
AIDS Research and Human Retroviruses|January 11, 2008
Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysisCatherine Seyler, Eugène Messou, Delphine Gabillard, et al.
American Journal of Respiratory and Critical Care Medicine|April 5, 2005
Risk factors for active tuberculosis after antiretroviral treatment initiation in AbidjanCatherine Seyler, Siaka Toure, Eugène Messou, et al.
AIDS (London, England)|March 8, 2005
Decreasing incidence of pregnancy by decreasing CD4 cell count in HIV-infected women in Côte d'Ivoire: a 7-year cohort studyMarc-Arthur Loko, Siaka Toure, Nicole Dakoury-Dogbo, et al.
Bulletin of the World Health Organization|October 20, 2015
New indicators for delay in initiation of antiretroviral treatment: estimates for CameroonJacques D A Ndawinz, Xavier Anglaret, Eric Delaporte, et al.
AIDS (London, England)|May 16, 2007
Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West AfricaCatherine Seyler, Christiane Adjé-Touré, Eugène Messou, et al.
Bulletin of the World Health Organization|June 24, 2008
Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adultsEugène Messou, Delphine Gabillard, Raoul Moh, et al.
Pageof 8